NP / PA
Corpus Christi Tots & Teens, PA
Corpus Christi Tots & Teens, PA was paid $3.70M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99393, Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) — 13% of everything it billed.
33Billing provider infoCORPUS CHRISTI TOTS & TEENS, PA
CORPUS CHRISTI, TX 78414
CORPUS CHRISTI, TX 78414
33aNPI1134250970assigned 03/07/2007
33bProvider typeFamily Nurse Practitioner
28Total paid$3.70M
24GClaims253,673
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Texas
Rank by total paid#4 of 344
Median peer was paid$14K
This provider vs. median267×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 790 | $19K | |
| 2019 | 151 | $3K | |
| 2020 | 5,540 | $71K | |
| 2021 | 55,963 | $762K | |
| 2022 | 70,918 | $1.08M | |
| 2023 | 67,931 | $1.01M | |
| 2024incomplete | 52,380 | $762K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 13% | 5,443 | 5,409 | $491K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 5,578 | 5,534 | $475K |
| 87428 | 11% | 6,141 | 5,927 | $404K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 11% | 4,027 | 4,010 | $392K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 10% | 4,471 | 4,417 | $373K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.5% | 28,552 | 13,579 | $352K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.5% | 41,581 | 35,812 | $314K |
| 99429 | 5.5% | 5,807 | 5,769 | $202K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.1% | 12,459 | 10,625 | $115K |
| 99381 | 2.4% | 983 | 974 | $88K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.1% | 7,256 | 6,927 | $77K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1.4% | 5,283 | 4,826 | $51K |
93 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 334 | $32K |
| 90461 | <1% | 7,945 | $28K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 590 | $27K |
| S8301 | Infection control supplies, not otherwise specified | <1% | 5,983 | $25K |
| 69210 | <1% | 624 | $23K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,652 | $21K |
| 83655 | <1% | 1,882 | $20K | |
| 99000 | <1% | 12,392 | $17K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,508 | $17K |
| 90480 | <1% | 426 | $14K | |
| 0001A | <1% | 291 | $11K | |
| 0071A | <1% | 270 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 801 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,552 | $10K |
| 96160 | <1% | 4,662 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 372 | $8K |
| 0072A | <1% | 177 | $7K | |
| 99050 | <1% | 62 | $7K | |
| 0002A | <1% | 169 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,137 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 330 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,464 | $4K |
| 99383 | <1% | 41 | $4K | |
| 90651 | <1% | 1,885 | $4K | |
| 0003A | <1% | 86 | $4K | |
| 0124A | <1% | 93 | $3K | |
| 0081A | <1% | 86 | $3K | |
| 99051 | <1% | 1,793 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,362 | $3K |
| 90620 | <1% | 1,299 | $3K | |
| 0154A | <1% | 62 | $2K | |
| 69209 | <1% | 168 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 760 | $2K |
| 0121A | <1% | 42 | $2K | |
| 90686 | <1% | 5,925 | $2K | |
| 0074A | <1% | 42 | $2K | |
| 96380 | <1% | 71 | $1K | |
| 96161 | <1% | 6,691 | $1K | |
| 87807 | <1% | 275 | $1K | |
| 0082A | <1% | 35 | $1K | |
| 81002 | <1% | 1,816 | $869.43 | |
| 0151A | <1% | 20 | $736.00 | |
| 94010 | <1% | 79 | $701.61 | |
| 92567 | <1% | 196 | $605.81 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 307 | $538.29 |
| 0004A | <1% | 12 | $437.44 | |
| 81025 | <1% | 270 | $437.04 | |
| 86318 | <1% | 115 | $367.43 | |
| 92551 | <1% | 3,648 | $216.43 | |
| 90715 | <1% | 939 | $141.40 | |
| 86308 | <1% | 239 | $126.93 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 702 | $114.09 |
| 94760 | <1% | 2,202 | $42.05 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 85 | $18.20 |
| 90619 | <1% | 1,073 | $0.58 | |
| 90656 | <1% | 895 | $0.01 | |
| 90734 | 0% | 662 | $0.00 | |
| 90707 | 0% | 934 | $0.00 | |
| 90633 | 0% | 2,089 | $0.00 | |
| 91300 | 0% | 738 | $0.00 | |
| 99173 | 0% | 6,151 | $0.00 | |
| 99080 | 0% | 2,802 | $0.00 | |
| 90710 | 0% | 1,017 | $0.00 | |
| 99177 | 0% | 540 | $0.00 | |
| 90670 | 0% | 2,137 | $0.00 | |
| 94664 | 0% | 925 | $0.00 | |
| 91312 | 0% | 171 | $0.00 | |
| 99188 | 0% | 230 | $0.00 | |
| 90671 | 0% | 791 | $0.00 | |
| 91320 | 0% | 116 | $0.00 | |
| 91308 | 0% | 178 | $0.00 | |
| 90380 | 0% | 108 | $0.00 | |
| 90680 | 0% | 2,748 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,910 | $0.00 |
| 90696 | 0% | 909 | $0.00 | |
| 90381 | 0% | 107 | $0.00 | |
| 90716 | 0% | 932 | $0.00 | |
| 36416 | 0% | 3,526 | $0.00 | |
| 90698 | 0% | 1,974 | $0.00 | |
| 90697 | 0% | 2,036 | $0.00 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 792 | $0.00 |
| 90744 | 0% | 581 | $0.00 | |
| 96127 | 0% | 1,431 | $0.00 | |
| 91318 | 0% | 93 | $0.00 | |
| 91307 | 0% | 638 | $0.00 | |
| 90677 | 0% | 1,074 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 332 | $0.00 |
| H0033 | Oral medication administration, direct observation | 0% | 16 | $0.00 |
| 91315 | 0% | 132 | $0.00 | |
| 94761 | 0% | 176 | $0.00 | |
| 91319 | 0% | 91 | $0.00 | |
| 99174 | 0% | 21 | $0.00 | |
| 91317 | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBORCHARD, EDWARD (PRESIDENT)